NOVARTIS CORP
2025–2026 federal contribution records · FEC Schedule A
01
Contribution summary
Loading the financial summary…
Reading the shared contribution publication for this cycle.
2025–2026 federal contribution records · FEC Schedule A
Loading the financial summary…
Reading the shared contribution publication for this cycle.
Federal contribution records grouped across normalized variants of this reported employer. Contributions are made by individuals, not by the employer.
Current-version rows · memo entries excluded from net amount
Last updated . These are the last published financial totals; newer source data is not included yet.
Across this cycle, 98,314 contributions come from electronic filings the FEC has not yet processed into its bulk data; those rows are replaced by the FEC version when it does.
Loading company overview…
These immutable labels appeared in FEC filings and are grouped under NOVARTIS CORP.
Showing the last published contribution snapshot. Newer source data is not included yet.
Top 10 contributors and top 10 recipients · independent of list pagination
Explore the reported connections for Novartis. Contributor and recipient lists are available below.
Data: GovMoneyGraph, based on FEC records. Groupings and recipient-party allocations are derived analysis, not FEC-verified identities or party registrations. Read our contribution and classification methodology.
Reported contributor groups, with evidence-based name-variant matching; not verified unique people · 10 per page
Showing 61–70 of 243 · largest absolute amount first
Reported name + ZIP cluster; not a verified identity merge · EAST HANOVER, NJ, 07936 · NOVARTIS · Healthcare & Pharmaceuticals · VP & HEAD, STAKEHOLDER ENGAGEMENT · 2 transaction rows
Other contributionsDerived from contributionsReported name + ZIP cluster; not a verified identity merge · EAST HANOVER, NJ, 07936 · NOVARTIS · Healthcare & Pharmaceuticals · VP MANAGED MARKETS FINANCE · 2 transaction rows
Other contributionsDerived from contributionsReported name + ZIP cluster; not a verified identity merge · EAST HANOVER, NJ, 07936 · NOVARTIS · Healthcare & Pharmaceuticals · HEAD, FEDERAL GOVERNMENT AFFAIRS · 2 transaction rows
Other contributionsDerived from contributionsReported name + ZIP cluster; not a verified identity merge · EAST HANOVER, NJ, 07936 · NOVARTIS · Healthcare & Pharmaceuticals · SVP, US TA HEAD ONCOLOGY · 2 transaction rows
Other contributionsDerived from contributionsEvidence-based cluster of 2 reported identities; not a verified identity merge · EAST HANOVER, NJ, 07936 · NOVARTIS · Healthcare & Pharmaceuticals · VP, HEAD OF US PUBLIC POLICY · Reported as NELSON, LISA / NELSON, LISA-2 · 2 transaction rows
Other contributionsDerived from contributionsReported name + ZIP cluster; not a verified identity merge · EAST HANOVER, NJ, 07936 · NOVARTIS · Healthcare & Pharmaceuticals · VP, NPS OPERATIONS, VENDOR MANAGEMENT · 2 transaction rows
Other contributionsDerived from contributionsReported name + ZIP cluster; not a verified identity merge · EAST HANOVER, NJ, 07936 · NOVARTIS · Healthcare & Pharmaceuticals · HEAD LEGAL PEOPLE AND ORGANIZATION · 2 transaction rows
Other contributionsDerived from contributionsReported name + ZIP cluster; not a verified identity merge · EAST HANOVER, NJ, 07936 · NOVARTIS · Healthcare & Pharmaceuticals · VICE PRESIDENT, HEAD LAUNCH MACHINE · 2 transaction rows
Other contributionsDerived from contributionsReported name + ZIP cluster; not a verified identity merge · EAST HANOVER, NJ, 07936 · NOVARTIS · Healthcare & Pharmaceuticals · VP, HEAD OF CONTENT LAB · 2 transaction rows
Other contributionsDerived from contributionsReported name + ZIP cluster; not a verified identity merge · BLUFFTON, SC, 29910 · NOVARTIS · Healthcare & Pharmaceuticals · SALES · 2 transaction rows
DemocraticDerived from contributionsWhere the contributions went · 10 per page
Showing 31–40 of 88 · largest absolute amount first
Hybrid PAC (qualified) · PORTLAND, OR · 2 transaction rows
DemocraticDerived from contributionsSenate campaign committee · NEWARK, NJ · BOOKER, CORY A. · U.S. Senate NJ 00 · 13 transaction rows
DemocraticDerived from contributionsSenate campaign committee · LITTLE ROCK, AR · SHOFFNER, HALLIE · U.S. Senate AR 00 · 2 transaction rows
DemocraticDerived from contributionsSenate campaign committee · ELLSWORTH, ME · PLATNER, GRAHAM · U.S. Senate ME 00 · 6 transaction rows
DemocraticDerived from contributionsHouse campaign committee · EDISON, NJ · HSU, JOHN · U.S. House NJ 06 · 15 transaction rows
DemocraticDerived from contributionsSenate campaign committee · AUSTIN, TX · TALARICO, JAMES · U.S. Senate TX 00 · 10 transaction rows
DemocraticDerived from contributionsHouse campaign committee · KINGSTON, NY · RYAN, PATRICK · U.S. House NY 18 · 3 transaction rows
DemocraticDerived from contributionsHouse campaign committee · NEWPORT, KY · MASSIE, THOMAS H. · U.S. House KY 04 · 10 transaction rows
RepublicanDerived from contributionsSenate campaign committee · NORTH CHARLESTON, SC · ANDREWS, ANNIE · U.S. Senate SC 00 · 10 transaction rows
DemocraticDerived from contributionsHouse campaign committee · NEWARK, NJ · MCIVER, LAMONICA · U.S. House NJ 10 · 3 transaction rows
DemocraticDerived from contributionsReported as NOVARTIS CORP
Industry classification summary
Novartis AG is a global pharmaceutical company verified by Forbes and official records as a major developer and manufacturer of innovative prescription medicines.
AI classification auto-approved under admin authorization
View source